Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy.

Kouri M, Kankaanranta L, Seppälä T, Tervo L, Rasilainen M, Minn H, Eskola O, Vähätalo J, Paetau A, Savolainen S, Auterinen I, Jääskeläinen J, Joensuu H.

Radiother Oncol. 2004 Jul;72(1):83-5.

PMID:
15236879
2.

Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.

Kankaanranta L, Seppälä T, Koivunoro H, Saarilahti K, Atula T, Collan J, Salli E, Kortesniemi M, Uusi-Simola J, Välimäki P, Mäkitie A, Seppänen M, Minn H, Revitzer H, Kouri M, Kotiluoto P, Seren T, Auterinen I, Savolainen S, Joensuu H.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e67-75. doi: 10.1016/j.ijrobp.2010.09.057. Epub 2011 Feb 6.

PMID:
21300462
3.

Boron neutron capture therapy (BNCT) followed by intensity modulated chemoradiotherapy as primary treatment of large head and neck cancer with intracranial involvement.

Kankaanranta L, Saarilahti K, Mäkitie A, Välimäki P, Tenhunen M, Joensuu H.

Radiother Oncol. 2011 Apr;99(1):98-9. doi: 10.1016/j.radonc.2011.02.008. Epub 2011 Mar 11. No abstract available.

PMID:
21397966
4.

1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose.

Timonen M, Kankaanranta L, Lundbom N, Collan J, Kangasmäki A, Kortesniemi M, Häkkinen AM, Lönngren A, Karjalainen S, Rasilainen M, Leinonen J, Huitti T, Jääskeläinen J, Kouri M, Savolainen S, Heikkinen S.

Eur J Radiol. 2005 Nov;56(2):154-9.

PMID:
16233888
5.

Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.

Kankaanranta L, Seppälä T, Koivunoro H, Saarilahti K, Atula T, Collan J, Salli E, Kortesniemi M, Uusi-Simola J, Mäkitie A, Seppänen M, Minn H, Kotiluoto P, Auterinen I, Savolainen S, Kouri M, Joensuu H.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):475-82. Epub 2007 Aug 6.

PMID:
17689034
6.

Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).

Henriksson R, Capala J, Michanek A, Lindahl SA, Salford LG, Franzén L, Blomquist E, Westlin JE, Bergenheim AT; Swedish Brain Tumour Study Group.

Radiother Oncol. 2008 Aug;88(2):183-91. doi: 10.1016/j.radonc.2006.04.015. Epub 2008 Mar 11.

PMID:
18336940
7.

[Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].

Pisarev MA, Dagrosa MA, Thomasz L, Juvenal G.

Medicina (B Aires). 2006;66(6):569-73. Review. Spanish.

PMID:
17240633
8.

Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.

Chadha M, Capala J, Coderre JA, Elowitz EH, Iwai J, Joel DD, Liu HB, Wielopolski L, Chanana AD.

Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):829-34.

PMID:
9531367
9.

Tumor blood vessel "normalization" improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer.

Molinari AJ, Pozzi EC, Monti Hughes A, Heber EM, Garabalino MA, Thorp SI, Miller M, Itoiz ME, Aromando RF, Nigg DW, Trivillin VA, Schwint AE.

Radiat Res. 2012 Jan;177(1):59-68. Epub 2011 Oct 10.

PMID:
21980958
10.

In vitro determination of toxicity, binding, retention, subcellular distribution and biological efficacy of the boron neutron capture agent DAC-1.

Tilly N, Olsson P, Hartman T, Coderre J, Makar M, Malmquist J, Sjöberg S, Pettersson J, Carlsson J, Glimelius B.

Radiother Oncol. 1996 Jan;38(1):41-50.

PMID:
8850425
11.

Boron neutron capture therapy of brain tumors: clinical trials at the finnish facility using boronophenylalanine.

Joensuu H, Kankaanranta L, Seppälä T, Auterinen I, Kallio M, Kulvik M, Laakso J, Vähätalo J, Kortesniemi M, Kotiluoto P, Serén T, Karila J, Brander A, Järviluoma E, Ryynänen P, Paetau A, Ruokonen I, Minn H, Tenhunen M, Jääskeläinen J, Färkkilä M, Savolainen S.

J Neurooncol. 2003 Mar-Apr;62(1-2):123-34.

PMID:
12749708
12.

Impact of intra-arterial administration of boron compounds on dose-volume histograms in boron neutron capture therapy for recurrent head-and-neck tumors.

Suzuki M, Sakurai Y, Nagata K, Kinashi Y, Masunaga S, Ono K, Maruhashi A, Kato I, Fuwa N, Hiratsuka J, Imahori Y.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1523-7. Epub 2006 Oct 23.

PMID:
17056200
13.

Boron neutron capture therapy: effects of split dose and overall treatment time.

Morris GM, Micca PL, Rezvani M, Hopewell JW, Coderre JA.

J Neurooncol. 2001 Apr;52(2):101-10.

PMID:
11508809
14.

Experimental application of boron neutron capture therapy to undifferentiated thyroid carcinoma.

Dagrosa MA, Viaggi M, Longhino J, Calzetta O, Cabrini R, Edreira M, Juvenal G, Pisarev MA.

Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):1084-92.

PMID:
14575840
15.

A novel concept of treatment of diffuse or multiple pleural tumors by boron neutron capture therapy (BNCT).

Suzuki M, Endo K, Satoh H, Sakurai Y, Kumada H, Kimura H, Masunaga S, Kinashi Y, Nagata K, Maruhashi A, Ono K.

Radiother Oncol. 2008 Aug;88(2):192-5. doi: 10.1016/j.radonc.2008.06.009. Epub 2008 Jul 22.

PMID:
18653257
16.

"Sequential" boron neutron capture therapy (BNCT): a novel approach to BNCT for the treatment of oral cancer in the hamster cheek pouch model.

Molinari AJ, Pozzi EC, Monti Hughes A, Heber EM, Garabalino MA, Thorp SI, Miller M, Itoiz ME, Aromando RF, Nigg DW, Quintana J, Santa Cruz GA, Trivillin VA, Schwint AE.

Radiat Res. 2011 Apr;175(4):463-72. doi: 10.1667/RR2148.1. Epub 2011 Feb 4.

PMID:
21294607
17.

[Boron neutron capture therapy (BNCT) as cancer treatment].

Joensuu H, Kankaanranta L, Tenhunen M, Saarilahti K.

Duodecim. 2011;127(16):1697-703. Review. Finnish.

PMID:
21972588
18.

Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.

Dagrosa MA, Viaggi M, Rebagliati RJ, Batistoni D, Kahl SB, Juvenal GJ, Pisarev MA.

Mol Pharm. 2005 Mar-Apr;2(2):151-6.

PMID:
15804189
19.

Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor.

Fukuda H, Hiratsuka J, Kobayashi T, Sakurai Y, Yoshino K, Karashima H, Turu K, Araki K, Mishima Y, Ichihashi M.

Australas Phys Eng Sci Med. 2003 Sep;26(3):97-103.

PMID:
14626847
20.

Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis.

Ariyoshi Y, Miyatake S, Kimura Y, Shimahara T, Kawabata S, Nagata K, Suzuki M, Maruhashi A, Ono K, Shimahara M.

Oncol Rep. 2007 Oct;18(4):861-6.

PMID:
17786347
Items per page

Supplemental Content

Write to the Help Desk